Studies Toward the Synthesis of Luminacin D: Assembly of Simplified Analogues Devoid of the Epoxide Displaying Antiangiogenic Activity

A series of structurally simplified luminacin analogues devoid of the epoxide ring are assembled in a stereocontrolled manner from 2,4-dimethoxybenzaldehyde using a syn-selective aldol reaction as the key step. The success of the approach is critically dependent on the
nature and extent of the alcohol protecting groups. The synthetic analogues inhibit VEGF-stimulated angiogenesis in an in vitro assay indicating
that the epoxide is not essential for biological activity in this compound class.